期刊文献+

心肌肌钙蛋白I和T联合检测在病毒性心肌炎诊断中的应用 被引量:8

Applications of cardic troponin T and cardic troponin I in diagnosis of viral myocarditis
下载PDF
导出
摘要 目的探讨肌钙蛋I(cTnI)和肌钙蛋白T(cTnT)在病毒性心肌炎(VMC)的诊断及病情观察方面的价值。方法对79例VMC患者进行入院后1、2、3周及2个月cTnT和心肌酶谱的动态监测;cTnT、cTnI与心电图(ECG)及病程关系的研究。结果急性VMC患者在各检测期内血清cTnT的阳性率(73.41%)和cTnI的阳性率(67.08%)显著高于心肌酶谱各项目(P<0.05):肌酸激酶47.44%、肌酸激酶同工酶51.28%、天冬氨酸氨基转移酶42.31%、乳酸脱氢酶42.31%、α-羟丁酸脱氢酶44.87%。cTnT和cTnI阳性组ECG正常率(5.26%、9.62%)明显低于阴性组(71.43%、57.69%)(P<0.05)。结论在VMC的诊断中,cTnT和cTnI可取代传统的心肌酶谱测定作为判断急性心肌炎的指标;同时cTnT和cTnI在VMC病情进展的观察中也具有重要意义。 Objective To investigate the utility of cardiac troponin T (cTnT) and cardiac troponin I (cTnI) in diagnosis and pathogenetic condition observation of viral myocarditis (VMC). Methods The serum levels of cTnT, cTnI and myocardial zymogram were monitored in 79 patients patients with viral myocarditis at 1 wk, 2 wk, 3 wk and 2 month timepoints after admission; in addition, the relationship of cTnT,cTnI and ECG change, course was investigated. Results In acute VMI patients,both the positive rate of cTnT(73.41% ) and cTnI (67.08%) were significantly higher than those of myocardial zymogram (CK 47.44%, CK-MB 51.28%, AST 42.31%, LDH 42.31%, α- HBDH 44.87%) (P〈0.05). The ECG normalraces in cTnT and cTnI positive group were much lower than those in cTnT and cTnI negative group (5. 26% and 9. 62% vs 71.43% and 57.69%, P〈0.05). Conclusion cTnT and cTnI can be used as useful alternatives to the mostly used biochemical items for diagnosing acute VMI. Moreover, the two items can also play an important role in minitoring the development of VMC.
出处 《检验医学与临床》 CAS 2008年第24期1473-1474,1476,共3页 Laboratory Medicine and Clinic
关键词 肌钙蛋白 心肌炎 实验室诊断 cardiac troponin myocarditis laboratory diagnosis
  • 相关文献

参考文献6

二级参考文献47

  • 1韩玉昆.新生儿缺氧缺血性脑病诊断依据和临床分度[J].中华儿科杂志,1997,35(2):99-100. 被引量:2786
  • 2吴铁吉.病毒性心肌炎诊断标准(修订草案)[J].中华儿科杂志,2000,38(2):75-75.
  • 3[17]Cardinale D,Sandri MT,Martinoni A,et al.Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy[J].J Am Coll Cardiol,2000,36(2):517
  • 4[18]Schulz O,Kromer A.Cardiac troponin I:a potential marker of exercise intolerance in patients with moderate heart failure[J].Am Heart J,2002,144(2):351
  • 5[19]Setsuta K,Seino Y,Ogawa T,et al.Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure[J].Am J Med,2002,113(9):717
  • 6[20]Pelsers MM,Hermens WT,Glatz JF.Fatty acid-binding proteins as plasma markers of tissue injury[J].Clin Chim Acta,2005,352(1-2):15
  • 7[21]Hansen MS,Stanton EB,Gawad Y,et al.Canadian profile investigators.Relation of circulating cardiac myosin light chain 1 isoform in stable severe congestive heart failure to survival and treatment with flosequinan[J].Am J Cardiol,2002,90:969
  • 8[22]Lemos JA,McGuire DK,Drazner MH.B-type natriuretic peptide in cardiovascular disease[J].Lancet,2003,362(9380):316
  • 9[23]Wieczorek SJ,Wu AH,Christenson R,et al.A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure:a multicenter evaluation[J].Am Heart J,2002,144(5):834
  • 10[24]Wang TJ,Larson MG,Levy D,ey al.Plasma natriuretic peptide level and the risk of cardiovascular events and death[J].Engl J Med,2004,350(7):655

共引文献39

同被引文献46

引证文献8

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部